Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Angelo Valerio Marzano, Concetta Potenza et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in ItalyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 32
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Giampiero Girolomoni, Paolo Gisondi et al.|Vaccines|2023Cited by 22
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologicsGeorgios Nikolakis, Christos C. Zouboulis, Erkan Alpsoy et al.|Journal of the European Academy of Dermatology and Venereology|2025Cited by 6